These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 19409154)

  • 1. Enhanced external counterpulsation for the treatment of stable angina and heart failure: a systematic review and economic analysis.
    McKenna C; McDaid C; Suekarran S; Hawkins N; Claxton K; Light K; Chester M; Cleland J; Woolacott N; Sculpher M
    Health Technol Assess; 2009 Apr; 13(24):iii-iv, ix-xi, 1-90. PubMed ID: 19409154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of enhanced external counterpulsation (EECP) for the treatment of stable angina in the United Kingdom.
    McKenna C; Hawkins N; Claxton K; McDaid C; Suekarran S; Light K; Chester M; Cleland JG; Woolacott N; Sculpher M
    Int J Technol Assess Health Care; 2010 Apr; 26(2):175-82. PubMed ID: 20392321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry).
    Soran O; Kennard ED; Kfoury AG; Kelsey SF;
    Am J Cardiol; 2006 Jan; 97(1):17-20. PubMed ID: 16377276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of enhanced external counterpulsation on Health-Related Quality of Life continue 12 months after treatment: a substudy of the Multicenter Study of Enhanced External Counterpulsation.
    Arora RR; Chou TM; Jain D; Fleishman B; Crawford L; McKiernan T; Nesto R; Ferrans CE; Keller S
    J Investig Med; 2002 Jan; 50(1):25-32. PubMed ID: 11813825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure.
    Feldman AM; Silver MA; Francis GS; Abbottsmith CW; Fleishman BL; Soran O; de Lame PA; Varricchione T;
    J Am Coll Cardiol; 2006 Sep; 48(6):1198-205. PubMed ID: 16979005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced external counterpulsation as treatment for chronic angina in patients with left ventricular dysfunction: a report from the International EECP Patient Registry (IEPR).
    Soran O; Kennard ED; Kelsey SF; Holubkov R; Strobeck J; Feldman AM
    Congest Heart Fail; 2002; 8(6):297-302. PubMed ID: 12461318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immediate and long-term outcome of enhanced external counterpulsation in treatment of chronic stable refractory angina.
    Loh PH; Louis AA; Windram J; Rigby AS; Cook J; Hurren S; Nikolay NP; Caplin J; Cleland JG
    J Intern Med; 2006 Mar; 259(3):276-84. PubMed ID: 16476105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating heart failure with enhanced external counterpulsation (EECP): design of the Prospective Evaluation of EECP in Heart Failure (PEECH) trial.
    Feldman AM; Silver MA; Francis GS; De Lame PA; Parmley WW
    J Card Fail; 2005 Apr; 11(3):240-5. PubMed ID: 15812754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes.
    Arora RR; Chou TM; Jain D; Fleishman B; Crawford L; McKiernan T; Nesto RW
    J Am Coll Cardiol; 1999 Jun; 33(7):1833-40. PubMed ID: 10362181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual high-grade angina after enhanced external counterpulsation therapy.
    McCullough PA; Henry TD; Kennard ED; Kelsey SF; Michaels AD;
    Cardiovasc Revasc Med; 2007; 8(3):161-5. PubMed ID: 17765644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced external counterpulsation and future directions: step beyond medical management for patients with angina and heart failure.
    Manchanda A; Soran O
    J Am Coll Cardiol; 2007 Oct; 50(16):1523-31. PubMed ID: 17936150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced external counterpulsation in the treatment of chronic refractory angina: a long-term follow-up outcome from the International Enhanced External Counterpulsation Patient Registry.
    Loh PH; Cleland JG; Louis AA; Kennard ED; Cook JF; Caplin JL; Barsness GW; Lawson WE; Soran OZ; Michaels AD
    Clin Cardiol; 2008 Apr; 31(4):159-64. PubMed ID: 18404725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does higher diastolic augmentation predict clinical benefit from enhanced external counterpulsation?: Data from the International EECP Patient Registry (IEPR).
    Michaels AD; Kennard ED; Kelsey SE; Holubkov R; Soran O; Spence S; Chou TM
    Clin Cardiol; 2001 Jun; 24(6):453-8. PubMed ID: 11403506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced external counterpulsation - effect on angina pectoris, QoL and exercise capacity after 1 year.
    May O; Lynggaard V; Mortensen JC; Malczynski J
    Scand Cardiovasc J; 2015 Feb; 49(1):1-6. PubMed ID: 25471629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immediate and one-year outcomes of dialysis patients with refractory angina treated by enhanced external counterpulsation.
    Wu CK; Hung HF; Leu JG; Tarng DC; Tsai MH; Chiang SS
    Clin Nephrol; 2014 Jul; 82(1):34-40. PubMed ID: 24691011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced External Counterpulsation for the relief of angina in patients with diabetes: safety, efficacy and 1-year clinical outcomes.
    Linnemeier G; Rutter MK; Barsness G; Kennard ED; Nesto RW;
    Am Heart J; 2003 Sep; 146(3):453-8. PubMed ID: 12947362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and efficacy of repeat enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry).
    Michaels AD; Barsness GW; Soran O; Kelsey SF; Kennard ED; Hui JC; Lawson WE;
    Am J Cardiol; 2005 Feb; 95(3):394-7. PubMed ID: 15670552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis.
    Rogowski W; Burch J; Palmer S; Craigs C; Golder S; Woolacott N
    Health Technol Assess; 2009 Jun; 13(31):iii-iv, ix-xi, 1-77. PubMed ID: 19573471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.